Antacid Market Size Worth USD 7.91 Billion by 2025 | CAGR: 3.9%: Grand View Research, Inc.

Antacid Market Size Worth USD 7.91 Billion by 2025 | CAGR: 3.9%: Grand View Research, Inc.

PR Newswire

SAN FRANCISCO, January 22, 2019

SAN FRANCISCO, January 22, 2019 /PRNewswire/ --

The global antacid market size is expected to reach USD 7.91 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Key suggestions from the report:  


Read 90 page research report with TOC on "Antacids Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Liquid), By Distribution Channel (Retail, Hospital, Online Pharmacy), By Region (APAC, Europe, North America), And Segment Forecasts, 2019 - 2025" at:  https://www.grandviewresearch.com/industry-analysis/antacids-market

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.

Connect with our analyst for specific inquiries about this market

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players are GlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.

Grand View Research has segmented the global antacid market based on dosage form, distribution channel, and region: 

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

Browse related reports by Grand View Research: 

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Voltar noticias em Inglês